Acura Pharmaceuticals, Inc. (ACUR) reported a net loss applicable to common stockholders for the fourth-quarter of $1.62 million or $0.03 per share, narrower than $2.9 million or $0.06 per share in the year-ago quarter.
The company did not generate any revenue in the latest quarter, compared to $359, 000 generated in the prior year quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.